Cholesterol, C-reactive protein, and cerebrovascular events following intensive and moderate statin therapy

Author： Mega Jessica Morrow David Cannon Christopher Murphy Sabina Cairns Richard Ridker Paul Braunwald Eugene

ISSN： 0929-5305

Source： Journal of Thrombosis and Thrombolysis, Vol.22, Iss.1, 2006-08, pp. : 71-76

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

C-reactive protein and coronary events following percutaneous coronary angioplasty

By de Winter R.J. Koch K.T. van Straalen J.P.

ACC Current Journal Review, Vol. 12, Iss. 6, 2003-11 ,pp. : 49-50

Elsevier

Access to resources Recommend Favorite

C-Reactive protein on admission and the success of thrombolytic therapy with streptokinase: is there any relation?

By Amasyali B. Kose S. Kilic A. Iyisoy A. Barcin C. Kursaklioglu H. Barindik N. Tokgoz S. Isik E. Demirtas E.

International Journal of Cardiology, Vol. 92, Iss. 1, 2003-11 ,pp. : 27-33

Elsevier

Access to resources Recommend Favorite

C-reactive protein: history and revival

By Ablij H.C. Meinders A.E.

European Journal of Internal Medicine, Vol. 13, Iss. 7, 2002-10 ,pp. : 412-422

Elsevier

Access to resources Recommend Favorite

C-Reactive Protein and Atherosclerosis: An Update

Vascular Disease Prevention, Vol. 5, Iss. 3, 2008-08 ,pp. : 178-182

Bentham Science Publishers

Access to resources Recommend Favorite

C-Reactive Protein Gene C1444T Polymorphism and Risk of Recurrent Ischemic Events in Patients with Symptomatic Intracranial Atherostenoses

Cerebrovascular Diseases, Vol. 28, Iss. 1, 2009-06 ,pp. : 95-102

Karger

Access to resources Recommend Favorite